Overview
Product name | Recombinant Human IGF-I Protein |
---|
Catalog No. | RP01608 |
---|
Description | Recombinant Human IGF-I Protein is produced by Pichia expression system. The target protein is expressed with sequence (Gly49-Ala118) of human IGF-I (Accession #NP_001104755.1) fused with no additional amino acid. |
---|
Bio-Activity | Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. The ED50 for this effect is typically 53.5-214.2 ng/mL.
|
---|
Purity | > 95% by SDS-PAGE. |
---|
Endotoxin | < 0.1 EU/μg of the protein by LAL method. |
---|
Formulation | Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4. |
---|
Species | Human |
---|
Calculated MW | 7.65 kDa |
---|
Product information
Synonym | IGF-1; IGF-I; IGF1A; IGFI; IGF?I; MGF; IGF1 |
---|
Expression Host | Pichia |
---|
Tag | No tag |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the vial before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.